StemCyte Inc. Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
StemCyte is a mid-sized biotechnology research firm based in Baldwin Park, California, founded in 1997. It focuses on expanding cell therapy applications to address currently incurable diseases. The company operates cord blood banks, including a public facility in Taiwan with more than 36,000 units, and it maintains both public and private cord blood programs worldwide. Over more than two decades, StemCyte has supplied cord blood units to more than 350 transplant centers around the world, supporting treatment across a range of diseases. In November 2024, StemCyte became the first private company to obtain FDA approval for a cord blood biologics license. It continued developing cord blood cell therapies and, in late 2025, announced the launch of a Public Bank Matching Protection Service in Taiwan in collaboration with Taishin Life.
1-888-653-2347 
support@leadiq.com 
